We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Puration Inc (CE) | USOTC:PURA | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
BAYSTREET -- June 18, 2020 -- InvestorsHub NewsWire -- via Glenn Wilkins --
It’s probably the farthest from the minds of many North Americans, given the worry over the coronavirus, and stress created by quarantines, but some companies are diligently at work on improving our sexual health.
The health-care sector in New York languished 0.4% around noon hour, while its counterpart up north, well, went north 0.4%.
Dallas-based Puration, Inc. (USOTC: PURA) today announced entering into a letter of intent to acquire a CBD infused sexual wellness product line. It would be the fourth such buy this year, and should close by the end of the month. The global sexual wellness market is anticipated to reach a $39-billion value by 2024.
PURA's revenue is generated today primarily through the sales of its EVERx CBD Sports Water. PURA reported $2.7 million in annual sales last year and $800,000 in the first quarter of 2020. In January of this year, PURA initiated an acquisition campaign to acquire CBD infused beverage, edible and topical businesses. The acquisition campaign is a long-term growth strategy while the COVID-19 Pandemic keeps PURA management focused on the first priority of sustaining rapid growth through its EVERx sales.
Puration shares rifled 5.8% higher early Thursday afternoon to 1.2 cents, on volume of 3.2 million shares.
Other problems such as diabetes are also front and center Thursday, with news that London, Ont.-based Sernova Corp. (TSX-Venture:SVA), a clinical-stage regenerative medicine therapeutics company, highlights positive results from its presentation to this week’s virtual conference of the American Diabetes Association.
CEO Philip Toleikis enthused, “The findings reported in diabetic patients, demonstrate that human donor islets transplanted into Sernova's Cell Pouch consistently demonstrate islet survival and the ability to produce the array of hormones required to treat diabetes.”
Shares in Sernova took their cue from the news, driving share prices up 1.5 cents, or 6.1%, to 26 cents, on a volume of 343,000 shares.
Original Publication - http://www.baystreet.ca/articles/stockstowatch/57976/Health-Stocks-Exhibit-Healthy-News-Robust-Share-Hikes
Also see recent BAYSTREET articles on Manganese X Energy Corp. (TSX-Venture: MN) and Kratos Defense & Security Solutions, Inc (NASDAQ:KTOS).
SOURCE: Glenn Wilkins
1 Year Puration (CE) Chart |
1 Month Puration (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions